S.Amdt. 2020Senate117th Congress (2021-2023)2nd degree
S.Amdt. 2020
Sponsored by
Sen. Cory A. Booker (D-NJ)
Submitted May 25, 2021
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
May 25, 2021
Text
Submitted
SA 2020. Mr. BOOKER submitted an amendment intended to be proposed to amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to establish a new Directorate for Technology and Innovation in the National Science Foundation, to establish a regional technology hub program, to require a strategy and report on economic security, science, research, innovation, manufacturing, and job creation, to establish a critical supply chain resiliency program, and for other purposes; which was ordered to lie on the table; as follows: At the end of subtitle A of title II of division C, insert the following: SEC. 3219L. FRAMEWORK FOR DISTRIBUTION OF COVID-19 VACCINES AROUND THE WORLD. (a) In General.--Not later than 30 days after the date of enactment of this Act, and every 30 days thereafter until the date that is one year after such date of enactment, the COVID-19 Task Force shall submit to the Committee on Foreign Relations, the Committee on Appropriations, and the Committee on Health, Education, Labor, and Pensions of the Senate, and to the Committee Foreign Affairs, the Committee on Appropriations, and the Committee on Energy and Commerce of the House of Representatives a report on the framework for the distribution around the world of COVID-19 vaccines produced in the United States. (b) Content.--The reports submitted under subsection (a) shall include updates, as appropriate, on the following: (1) The number of vaccines procured by the United States and distributed through COVAX or through other bilateral or multilateral agreements. (2) The number of vaccines procured by the United States that the Federal Government has allocated for potential future distribution through COVAX or through other bilateral or multilateral agreements. (3) A framework for how countries will be prioritized for the delivery of COVID-19 vaccines provided directly by the Federal Government. (4) A review of deployments of health and diplomatic personnel overseas engaged in COVID-19 response efforts. ______